Beth H Shaz

InstitutionNew York Blood Center
AddressNew York
New York
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 4 publications in June 2020
    All Publications
    Bar chart showing 107 publications over 17 distinct years, with a maximum of 15 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR. COVID-19 convalescent plasma: Interim recommendations from the AABB. Transfusion. 2021 04; 61(4):1313-1323. PMID: 33586160.
      Citations: 9     Fields:    Translation:Humans
    2. Shaz BH, Cohn CS. Catch those antibodies before they fall. Blood. 2020 11 26; 136(22):2489-2490. PMID: 33242330.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Nguyen FT, van den Akker T, Lally K, Lam H, Lenskaya V, Liu STH, Bouvier NM, Aberg JA, Rodriguez D, Krammer F, Strauss D, Shaz BH, Rudon L, Galdon P, Jhang JS, Arinsburg SA, Baine I. Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2. Transfusion. 2021 01; 61(1):78-93. PMID: 33125158.
      Citations: 3     Fields:    Translation:Humans
    4. Tobian AAR, Shaz BH. Earlier the better: convalescent plasma. Blood. 2020 08 06; 136(6):652-654. PMID: 32761223.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    5. Ragnesola B, Jin D, Lamb CC, Shaz BH, Hillyer CD, Luchsinger LL. COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors. BMC Res Notes. 2020 Aug 06; 13(1):372. PMID: 32762746.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    6. Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 16; 21(1):536. PMID: 32546220.
      Citations:    Fields:    
    7. Budhai A, Wu AA, Hall L, Strauss D, Paradiso S, Alberigo J, Hillyer CD, Jett B, Tobian AAR, Bloch EM, Sachais BS, Shaz BH. How did we rapidly implement a convalescent plasma program? Transfusion. 2020 07; 60(7):1348-1355. PMID: 32449169.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    8. Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 08; 21(1):499. PMID: 32513308.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    9. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765. PMID: 32254064.
      Citations: 312     Fields:    Translation:HumansCellsPHPublic Health